Omeros Corporation (OMER) Leaps on Study Data

Omeros Corporation (NASDAQ: OMER) shares climbed 65.2% to $24.03, as the company reported additional positive data in its Phase 2 clinical trial of OMS721. Share volume was 1.4 million, towering over an all-day average of 166,000